enVVeno Medical (NVNO) Expected to Announce Earnings on Thursday

enVVeno Medical (NASDAQ:NVNO - Get Free Report) is expected to be announcing its Q4 2024 earnings results before the market opens on Thursday, February 27th. Analysts expect the company to announce earnings of ($0.35) per share for the quarter.

enVVeno Medical (NASDAQ:NVNO - Get Free Report) last announced its earnings results on Thursday, February 27th. The company reported ($0.30) earnings per share for the quarter, topping the consensus estimate of ($0.35) by $0.05. On average, analysts expect enVVeno Medical to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

enVVeno Medical Stock Down 9.9 %

NVNO traded down $0.35 on Friday, hitting $3.18. 239,342 shares of the company traded hands, compared to its average volume of 111,170. enVVeno Medical has a 12-month low of $2.45 and a 12-month high of $6.97. The company has a 50 day moving average of $3.28 and a 200-day moving average of $3.68. The stock has a market capitalization of $55.76 million, a PE ratio of -2.47 and a beta of 1.22.

About enVVeno Medical

enVVeno Medical Corporation Nasdaq: NVNO is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company's lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).